Influenza A/Texas/71/2017 (H3N2)
Pro00114712
Phase 1 mab completed
Quick answer
Influenza A/Texas/71/2017 (H3N2) for Influenza Viral Infections is a Phase 1 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Influenza Viral Infections
- Phase
- Phase 1
- Modality
- mab
- Status
- completed